143 related articles for article (PubMed ID: 16277674)
1. Absence of autoantibodies against correctly folded recombinant fibrillin-1 protein in systemic sclerosis patients.
Brinckmann J; Hunzelmann N; El-Hallous E; Krieg T; Sakai LY; Krengel S; Reinhardt DP
Arthritis Res Ther; 2005; 7(6):R1221-6. PubMed ID: 16277674
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin-1, in patients with scleroderma and other connective tissue diseases.
Tan FK; Arnett FC; Antohi S; Saito S; Mirarchi A; Spiera H; Sasaki T; Shoichi O; Takeuchi K; Pandey JP; Silver RM; LeRoy C; Postlethwaite AE; Bona CA
J Immunol; 1999 Jul; 163(2):1066-72. PubMed ID: 10395706
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to fibrillin 1 in systemic sclerosis: ethnic differences in antigen recognition and lack of correlation with specific clinical features or HLA alleles.
Tan FK; Arnett FC; Reveille JD; Ahn C; Antohi S; Sasaki T; Nishioka K; Bona CA
Arthritis Rheum; 2000 Nov; 43(11):2464-71. PubMed ID: 11083269
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin 1, in patients with localized scleroderma.
Arnett FC; Tan FK; Uziel Y; Laxer RM; Krafchik BR; Antohi S; Bona C
Arthritis Rheum; 1999 Dec; 42(12):2656-9. PubMed ID: 10616014
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies to fibrillin-1 activate normal human fibroblasts in culture through the TGF-beta pathway to recapitulate the "scleroderma phenotype".
Zhou X; Tan FK; Milewicz DM; Guo X; Bona CA; Arnett FC
J Immunol; 2005 Oct; 175(7):4555-60. PubMed ID: 16177099
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous occurrence of anti-fibrillin-1 autoantibodies in tight-skin mice.
Murai C; Saito S; Kasturi KN; Bona CA
Autoimmunity; 1998; 28(3):151-5. PubMed ID: 9867127
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis and fibrillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti-endothelial cell antibodies.
Ahmed SS; Tan FK; Arnett FC; Jin L; Geng YJ
Arthritis Rheum; 2006 Jul; 54(7):2250-62. PubMed ID: 16802364
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies in systemic sclerosis (scleroderma): clues for clinical evaluation, prognosis and pathogenesis.
Grassegger A; Pohla-Gubo G; Frauscher M; Hintner H
Wien Med Wochenschr; 2008; 158(1-2):19-28. PubMed ID: 18286246
[TBL] [Abstract][Full Text] [Related]
9. Anti-fibrillin-1 autoantibodies in systemic sclerosis are GM and KM allotype-restricted.
Pandey JP; Page GP; Silver RM; LeRoy EC; Bona CA
Exp Clin Immunogenet; 2001; 18(3):123-9. PubMed ID: 11549841
[TBL] [Abstract][Full Text] [Related]
10. Fibrillin-1 protein in tight skin mice and scleroderma.
Bona C; Saito S
Clin Rev Allergy Immunol; 2000 Feb; 18(1):119-26. PubMed ID: 10907111
[No Abstract] [Full Text] [Related]
11. Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide.
Villano M; Borghini A; Manetti M; Gabbrielli E; Rossi A; Sestini P; Milia A; Nacci F; Guiducci S; Matucci-Cerinic M; Ibba-Manneschi L; Weber E
Arthritis Res Ther; 2013 Aug; 15(4):R90. PubMed ID: 23962393
[TBL] [Abstract][Full Text] [Related]
12. Abnormalities in fibrillin 1-containing microfibrils in dermal fibroblast cultures from patients with systemic sclerosis (scleroderma).
Wallis DD; Tan FK; Kielty CM; Kimball MD; Arnett FC; Milewicz DM
Arthritis Rheum; 2001 Aug; 44(8):1855-64. PubMed ID: 11508439
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of anti-fibrillin-1 autoantibodies in MCTD and CREST syndrome.
Lundberg I; Antohi S; Takeuki K; Arnett F; Steiner G; Brumeanu TD; Klareskog L; Bona C
J Autoimmun; 2000 May; 14(3):267-74. PubMed ID: 10756089
[TBL] [Abstract][Full Text] [Related]
14. Fibrillin in Marfan syndrome and tight skin mice provides new insights into transforming growth factor-beta regulation and systemic sclerosis.
Lemaire R; Bayle J; Lafyatis R
Curr Opin Rheumatol; 2006 Nov; 18(6):582-7. PubMed ID: 17053502
[TBL] [Abstract][Full Text] [Related]
15. Fine specificity of anti-fibrillin-1 autoantibodies in primary pulmonary hypertension syndrome.
Morse JH; Antohi S; Kasturi K; Saito S; Fotino M; Humbert M; Simonneau G; Basst RJ; Bona CA
Scand J Immunol; 2000 Jun; 51(6):607-11. PubMed ID: 10849372
[TBL] [Abstract][Full Text] [Related]
16. Fibrillin-1: organization in microfibrils and structural properties.
Reinhardt DP; Keene DR; Corson GM; Pöschl E; Bächinger HP; Gambee JE; Sakai LY
J Mol Biol; 1996 Apr; 258(1):104-16. PubMed ID: 8613981
[TBL] [Abstract][Full Text] [Related]
17. Serum fibrillin-antifibrillin immune complexes among diabetic children.
Nicoloff G; Angelova M; Nikolov A
Vascul Pharmacol; 2005 Sep; 43(3):171-5. PubMed ID: 16095978
[TBL] [Abstract][Full Text] [Related]
18. Epitope Specificity Determines Pathogenicity and Detectability of Anti-Platelet-Derived Growth Factor Receptor α Autoantibodies in Systemic Sclerosis.
Moroncini G; Grieco A; Nacci G; Paolini C; Tonnini C; Pozniak KN; Cuccioloni M; Mozzicafreddo M; Svegliati S; Angeletti M; Kazlauskas A; Avvedimento EV; Funaro A; Gabrielli A
Arthritis Rheumatol; 2015 Jul; 67(7):1891-903. PubMed ID: 25808833
[TBL] [Abstract][Full Text] [Related]
19. Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis.
Sato S; Hayakawa I; Hasegawa M; Fujimoto M; Takehara K
J Invest Dermatol; 2003 Apr; 120(4):542-7. PubMed ID: 12648215
[TBL] [Abstract][Full Text] [Related]
20. Mutant fibrillin 1 from tight skin mice increases extracellular matrix incorporation of microfibril-associated glycoprotein 2 and type I collagen.
Lemaire R; Farina G; Kissin E; Shipley JM; Bona C; Korn JH; Lafyatis R
Arthritis Rheum; 2004 Mar; 50(3):915-26. PubMed ID: 15022335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
